This statistic displays the ten most expensive Medicare Part B payments for cancer (and selected other) drugs delivered in the physician office and at home by total Medicare annual payments in 2014. During this time, annual Medicare payments for Denosumab injections totaled some 505.9 million U.S. dollars. The size and demographic of medical professionals in oncology plays a significant role in the accessibility and quality of cancer care for patients in the United States.
Top 10 cancer drugs based on annual Medicare Part B payments in 2014
(in million U.S. dollars)
Values are for drugs delivered in the physician office and at home.
* Drugs used for treatment of patients with cancer. Pricing data reflects 4th quarter 2014 payment rates, which correspond to 2nd quarter 2014 manufacturer reports.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
American Society of Clinical Oncology. (March 17, 2016). Top 10 cancer drugs based on annual Medicare Part B payments in 2014 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 03, 2024, from https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/
American Society of Clinical Oncology. "Top 10 cancer drugs based on annual Medicare Part B payments in 2014 (in million U.S. dollars)." Chart. March 17, 2016. Statista. Accessed December 03, 2024. https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/
American Society of Clinical Oncology. (2016). Top 10 cancer drugs based on annual Medicare Part B payments in 2014 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 03, 2024. https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/
American Society of Clinical Oncology. "Top 10 Cancer Drugs Based on Annual Medicare Part B Payments in 2014 (in Million U.S. Dollars)." Statista, Statista Inc., 17 Mar 2016, https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/
American Society of Clinical Oncology, Top 10 cancer drugs based on annual Medicare Part B payments in 2014 (in million U.S. dollars) Statista, https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/ (last visited December 03, 2024)
Top 10 cancer drugs based on annual Medicare Part B payments in 2014 (in million U.S. dollars) [Graph], American Society of Clinical Oncology, March 17, 2016. [Online]. Available: https://www.statista.com/statistics/418660/most-expensive-annual-medicare-payments-for-cancer-drugs-us/
